Search by Drug Name or NDC
NDC 43066-0150-10 Nexterone 1.5 mg/mL Details
Nexterone 1.5 mg/mL
Nexterone is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is AMIODARONE HYDROCHLORIDE.
Product Information
| NDC | 43066-0150 |
|---|---|
| Product ID | 43066-150_b3d4e148-3bc1-4c80-8df7-5006a77c813d |
| Associated GPIs | 35400005112020 |
| GCN Sequence Number | 067475 |
| GCN Sequence Number Description | amiodarone in dextrose,iso-osm PLAST. BAG 150MG/0.1L INTRAVEN |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 30039 |
| HICL Sequence Number | 037678 |
| HICL Sequence Number Description | AMIODARONE IN DEXTROSE, ISO-OSMOTIC |
| Brand/Generic | Brand |
| Proprietary Name | Nexterone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | amiodarone hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | AMIODARONE HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Antiarrhythmic [EPC], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022325 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43066-0150-10 (43066015010)
| NDC Package Code | 43066-150-10 |
|---|---|
| Billing NDC | 43066015010 |
| Package | 100 mL in 1 BAG (43066-150-10) |
| Marketing Start Date | 2010-11-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |